FDA clears Johnson & Johnson hepatitis C drug

Home › FDA clears Johnson & Johnson hepatitis C drug

The U.S. Food and Drug Administration said Friday it approved the drug, a protease inhibitor that blocks a protein needed by the virus to replicate.

02.07	Chattanooga Area High School Students Graduate from BASFs TECH Academy
02.07	Atlantic Tropical Weather Outlook
02.07	Fayette Pipe Transforms Black Steel Pipe with FayetteGuard
02.07	Hurricane Beryl Graphics
02.07	Hurricane Beryl Public Advisory Number 16A
02.07	Summary for Hurricane Beryl (AT2/AL022024)
02.07	Eastern North Pacific Tropical Weather Outlook
02.07	Automotive Coatings to Reach $19B by 2028: MarketsandMarkets
More »

je.st